Provigil Maker Cited for False ‘Fatigue’ Promotion

The Food and Drug Administration has sent a warning letter to the manufacturer of modafinil about promoting the drug for the treatment of fatigue associated with some neurologic and psychiatric disorders for which the drug is not approved.